These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 10927944

  • 1. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
    Fu LS, Chi CS.
    Acta Paediatr Taiwan; 2000; 41(2):80-4. PubMed ID: 10927944
    [Abstract] [Full Text] [Related]

  • 2. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS, Shien CY, Chi CS.
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [Abstract] [Full Text] [Related]

  • 3. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO, Kari JA.
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [Abstract] [Full Text] [Related]

  • 4. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [Abstract] [Full Text] [Related]

  • 8. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
    Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
    [Abstract] [Full Text] [Related]

  • 9. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
    Esezobor CI, Ladapo TA, Lesi FE.
    Niger J Clin Pract; 2016 Jul; 19(2):254-8. PubMed ID: 26856291
    [Abstract] [Full Text] [Related]

  • 10. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 11. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
    Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
    Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 17. Levamisole Therapy as a Second-line Immunosuppressive Agent in Corticosteroid-sensitive Nephrotic Syndrome in Children.
    Al-Ibrahim AA, Al-Kharraz SM, Al-Sadoon DM, Al-Madani AJ, Al-Musallam SA.
    Saudi J Kidney Dis Transpl; 2003 Jan; 14(2):153-7. PubMed ID: 18209440
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Kurupong T, Chaiyapak T, Piyaphanee N, Pattaragarn A, Sumboonnanonda A.
    J Med Assoc Thai; 2013 Jan; 96(1):33-40. PubMed ID: 23720975
    [Abstract] [Full Text] [Related]

  • 19. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
    Banerjee S, Sengupta J, Sinha R, Chatterjee S, Sarkar S, Akhtar S, Saha R, Pahari A.
    Pediatr Nephrol; 2024 Oct; 39(10):2969-2977. PubMed ID: 38822220
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
    BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.